Post-transplant lymphoproliferative disorder after adult-to-adult living donor liver transplant: Case series and review of literature

Leukemia and Lymphoma

Volumn 51, Issue 8, 2010, Pages 1494-1501

  Kataoka, Keisuke ^a,b   Seo, Sachiko ^a   Sugawara, Yasuhiko ^a   Ota, Satoshi ^a   Imai, Yoichi ^a   Takahashi, Tsuyoshi ^a   Fukayama, Masashi ^a   Kokudo, Norihiro ^a   Kurokawa, Mineo ^a,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

EpsteinBarr virus; hepatitis C virus; living donor liver transplant; post transplant lymphoproliferative disorder

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; T LYMPHOCYTE ANTIBODY; TACROLIMUS; VINCRISTINE;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; BILIARY CIRRHOSIS; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CAUSE OF DEATH; CONTINUOUS INFUSION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FEMALE; GENE REARRANGEMENT; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LARGE CELL LYMPHOMA; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ONCOGENE C MYC; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; TREATMENT WITHDRAWAL;

ADOLESCENT; ADULT; AGED; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; REVIEW LITERATURE AS TOPIC; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955449043     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.492063     Document Type: Article

References (40)

1. Gottschalk S, Rooney CM, Heslop HE. Post-transplant lymphoproliferative disorders. Annu Rev Med 2005;56:29-44.
2. Taylor AL, Marcus R, Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol 2005;56:155-167.
3. Leblond V, Choquet S. Lymphoproliferative disorders after liver transplantation. J Hepatol 2004;40:728-735.
4. Ben-Ari Z, Amlot P, Lachmanan SR, Tur-Kaspa R, Rolles K, Burroughs AK. Post-transplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome. Liver Transpl Surg 1999;5:184-191.
5. WuL, Rappaport DC,HanbidgeA,Merchant N, Shepherd FA, Greig PD. Lymphoproliferative disorders after liver transplantation: imaging features. Abdom Imaging 2001;26:200-206.
6. Lemoine A, Pham P, Azoulay D, et al. Detection of gammopathy by serum protein electrophoresis for predicting and managing therapy of lymphoproliferative disorder in 911 recipients of liver transplants. Blood 2001;98:1332-1338.
7. Jain A, Nalesnik M, Reyes J, et al. Post-transplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg 2002;236:429-436; discussion 436-1427
8. Duvoux C, Pageaux GP, Vanlemmens C, et al. Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients. Transplantation 2002;74: 1103-1109.
9. Kremers WK, Devarbhavi HC, Wiesner RH, Krom RA, Macon WR, Habermann TM. Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival. Am J Transplant 2006;6:1017-1024.
10. Avolio AW, Agnes S, Barbarino R, et al. Post-transplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series. Transplant Proc 2007;39:1956-1960.
11. Patel H, Vogl DT, Aqui N, et al. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen cases. Leuk Lymphoma 2007;48:885-891.
12. Koch DG, Christiansen L, Lazarchick J, Stuart R, Willner IR, Reuben A. Post-transplantation lymphoproliferative disorder- the great mimic in liver transplantation: Appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus. Liver Transpl 2007;13:904-912.
13. Dhillon MS, Rai JK, Gunson BK, Olliff S, Olliff J. Posttransplant lymphoproliferative disease in liver transplantation. Br J Radiol 2007;80:337-346.
14. Brown RS Jr. Live donors in liver transplantation. Gastroenterology 2008;134:1802-1813.
15. Trotter JF, Wachs M, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 2002;346:1074-1082.
16. Kawano N, Shimoda K, Ishikawa F, et al. Adult T-cell leukemia development from a human T-cell leukemia virus type I carrier after a living-donor liver transplantation. Transplantation 2006;82:840-843.
17. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995;333:333-336.
18. Cosio FG, Grande JP, Larson TS, et al. Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant 2005;5:1130-1136.
19. Krieger NR, Becker BN, Heisey DM, et al. Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. Transplantation 2003;75:1677-1682.
20. Jassem W, Koo DD, Cerundolo L, Rela M, Heaton ND, Fuggle SV. Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation 2003;75:2001-2007.
21. Jassem W, Koo DD, Cerundolo L, Rela M, Heaton ND, Fuggle SV. Cadaveric versus living-donor livers: differences in inflammatory markers after transplantation. Transplantation 2003;76:1599-1603.
22. Weiss S, Kotsch K, Francuski M, et al. Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 2007;7:1584-1593.
23. Raymond E, Tricottet V, Samuel D, Reynes M, Bismuth H, Misset JL. Epstein-Barr virus-related localized hepatic lymphoproliferative disorders after liver transplantation. Cancer 1995;76:1344-1351.
24. Dulundu E, Sugawara Y, Makuuchi M. Revolution and refinement of surgical techniques for living donor partial liver transplantation. Yonsei Med J 2004;45:1076-1088.
25. Tamura S, Sugawara Y, Kishi Y, et al. Conversion to cyclosporine provides valuable rescue therapy for living donor adult liver transplant patients intolerant to tacrolimus: a single-center experience at the University of Tokyo. Transplant Proc 2004;36:3242-3244.
26. Terminology for hepatic allograft rejection. International Working Party. Hepatology 1995;22:648-654.
27. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997;25:658-663.
28. Akamatsu N, Sugawara Y, Kaneko J, Kishi Y, Makuuchi M. Risk factors of cytomegalovirus infection after living donor liver transplantation. Hepatogastroenterology 2005;52:197-199.
29. Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008.
30. Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood 2004;104:3009-3020.
31. Dotti G, Fiocchi R, Motta T, et al. Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant. Transplantation 2000;69:827-833.
32. Ghobrial IM, Habermann TM, Macon WR, et al. Differences between early and late post-transplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases? Transplantation 2005;79:244-247.
33. de Jonge J, Kurian S, Shaked A, et al. Unique early gene expression patterns in human adult-to-adult living donor liver grafts compared to deceased donor grafts. Am J Transplant 2009;9:758-772.
34. van Leeuwen MT, Grulich AE, Webster AC, et al. Immunosuppression and other risk factors for early and late non- Hodgkin lymphoma after kidney transplantation. Blood 2009;114:630-637.
35. Aucejo F, Rofaiel G, Miller C. Who is at risk for posttransplant lymphoproliferative disorders (PTLD) after liver transplantation? J Hepatol 2006;44:19-23.
36. Morton LM, Landgren O, Chatterjee N, et al. Hepatitis C virus infection and risk of post-transplantation lymphoproliferative disorder among solid organ transplant recipients. Blood 2007;110:4599-4605.
37. Maecker B, Jack T, Zimmermann M, et al. CNS or bone marrow involvement as risk factors for poor survival in posttransplantation lymphoproliferative disorders in children after solid organ transplantation. J Clin Oncol 2007;25:4902-4908.
38. Oertel SH, Verschuuren E, Reinke P, et al. Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). Am J Transplant 2005;5:2901-2906.
39. Choquet S, Leblond V, Herbrecht R, et al. Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood 2006;107:3053-3057.
40. Mamzer-Bruneel MF, Lome C, Morelon E, et al. Durable remission after aggressive chemotherapy for very late postkidney transplant lymphoproliferation: a report of 16 cases observed in a single center. J Clin Oncol 2000;18: 3622-3632.